SRx Health Solutions Appoints Joshua Epstein to Board of Directors

• SRx Health Solutions appoints Joshua Epstein to Board of Directors and Compensation Committee. • Epstein brings expertise in digital health and data analytics. • Forward-looking statements in press release. • Private Securities Litigation Reform Act of 1995 applies.

SRx Health Solutions (NYSE American: SRXH) has announced the appointment of Joshua Epstein to its Board of Directors and Compensation Committee. The announcement, made on October 1, 2025, reflects a strategic move to bolster the company's governance structure with Epstein's expertise in digital health and data analytics SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee^[1].

The press release, issued by SRx Health Solutions, Inc., states that Epstein's appointment is part of a straightforward addition to the company's governance structure. The announcement includes forward-looking statements, which are subject to the Private Securities Litigation Reform Act of 1995 SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee^[1]. These statements highlight the company's expectations about future events and financial trends, emphasizing that actual results may differ from projections.

The press release also includes standard contact information for further inquiries. Investors are advised to refer to the company's filings with the SEC for additional risk factors and forward-looking statements.

SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254